MOTS-c is studied to better understand mitochondrial signaling, metabolic regulation, and how mitochondria communicate with the rest of the cell under stress.

MOTS-c occupies a genuinely novel position in metabolic peptide research. Unlike most signaling peptides encoded in the nuclear genome, MOTS-c is transcribed from mitochondrial DNA — specifically from within the 12S rRNA gene sequence — placing it at the intersection of mitochondrial biology and systemic metabolic signaling in a way that has reshaped understanding of how mitochondria communicate with the rest of the cell and with distant tissues.

Its primary characterized mechanism involves AMPK pathway activation through endogenous AICAR accumulation in skeletal muscle cell preparations — a metabolic stress sensing pathway central to glucose uptake, fatty acid oxidation, and mitochondrial biogenesis research. What makes MOTS-c particularly interesting as a research tool is a second, unexpected mechanism: under oxidative stress conditions, MOTS-c undergoes nuclear translocation and directly engages antioxidant response element (ARE) transcriptional machinery alongside NRF2 — a behavior not previously associated with mitochondria-derived peptides and one that significantly expands its research utility into nuclear gene regulation and stress response pathway biology.

Together, these two mechanisms — cytoplasmic AMPK activation and stress-triggered nuclear ARE engagement — make MOTS-c a multi-compartment signaling tool compound relevant across metabolic, mitochondrial, and redox biology research disciplines.

• CAS Number: 1627580-64-6
• Molecular Weight: ~2174.64 g/mol
• Purity: ≥99%
• Also Known As: Mitochondrial Open Reading Frame of the Twelve S rRNA-c, MDP (Mitochondria-Derived Peptide), 12S rRNA-encoded peptide
• Chemical Formula: C₁₀₁H₁₅₂N₂₈O₂₂S₂

In cell-based and preclinical models, MOTS-c activates AMPK through an indirect but well-characterized metabolic mechanism. By inhibiting the de novo purine biosynthesis pathway in skeletal muscle cell preparations, MOTS-c drives intracellular accumulation of AICAR (5-aminoimidazole-4-carboxamide ribonucleotide) — an endogenous AMPK activator. This AICAR-mediated AMPK activation subsequently engages downstream glucose transporter translocation, fatty acid oxidation signaling, and mitochondrial biogenesis pathway activity in muscle cell preparations, consistent with AMPK’s established role as a central metabolic stress sensor.

A second mechanistic arm operates under conditions of metabolic stress. When skeletal muscle and human cell line preparations are exposed to glucose restriction or oxidative challenge (H₂O₂), MOTS-c undergoes nuclear translocation — confirmed by immunofluorescence and nuclear fractionation experiments across multiple human cell lines. Once in the nucleus, MOTS-c interacts with ARE transcriptional machinery and the NRF2 transcription factor, upregulating antioxidant and cytoprotective gene network expression in a stress-responsive pattern. This nuclear signaling behavior is mechanistically distinct from its cytoplasmic AMPK activity and represents an unexpected dual-compartment signaling profile for a mitochondria-derived peptide.

The combination of AMPK-mediated metabolic pathway regulation and NRF2/ARE-driven antioxidant gene expression makes MOTS-c a uniquely multi-layered tool compound for studying how mitochondrial-origin signals coordinate cytoplasmic and nuclear responses to metabolic and oxidative stress in cell-based research systems.

• AMPK Pathway Activation and AICAR Accumulation Studies
• Mitochondrial-Encoded Peptide Biology and MDP Signaling Research
• Skeletal Muscle Glucose Metabolism and Insulin Sensitivity Models
• NRF2/ARE Antioxidant Response Element and Nuclear Translocation Studies
• Oxidative Stress and Cytoprotective Gene Network Research
• De Novo Purine Biosynthesis Pathway Inhibition Studies